Mild Acidosis Enhances AMPA Receptor-Mediated Intracellular Zinc Mobilization in Cortical Neurons
- 5 Downloads
Overactivation of glutamate receptors and subsequent deregulation of the intraneuronal calcium ([Ca2+]i) levels are critical components of the injurious pathways initiated by cerebral ischemia. Another hallmark of stroke is parenchymal acidosis, and we have previously shown that mild acidosis can act as a switch to decrease NMDAR-dependent neuronal loss while potentiating the neuronal loss mediated by AMPARs. Potentiation of AMPAR-mediated neuronal death in an acidotic environment was originally associated only with [Ca2+]i dyshomeostasis, as assessed by Ca2+ imaging; however, intracellular dyshomeostasis of another divalent cation, Zn2+, has recently emerged as another important co-factor in ischemic neuronal injury. Rises in [Zn2+]i greatly contribute to the fluorescent changes of Ca2+-sensitive fluorescent probes, which also have great affinity for Zn2+. We therefore revisited our original findings (Mcdonald et al., 1998) and investigated if AMPAR-mediated fura-2 signals we observed could also be partially due to [Zn2+]i increases. Fura-2 loaded neuronal cultures were exposed to the AMPAR agonist, kainate, in a physiological buffer at pH 7.4 and then washed either at pH 7.4 or pH 6.2. A delayed recovery of fura-2 signals was observed at both pHs. Interestingly this impaired recovery phase was found to be sensitive to chelation of intracellular Zn2+. Experiments with the Zn2+ sensitive (and Ca2+-insensitive) fluorescent probe FluoZin-3 confirmed the idea that AMPAR activation increases [Zn2+]i, a phenomenon that is potentiated by mild acidosis. Additionally, our results show that selective Ca2+ imaging mandates the use of intracellular heavy metal chelators to avoid confounding effects of endogenous metals such as Zn2+.
Excitotoxicity is a key phenomenon that promotes neuronal demise in cerebral ischemia (1). Evidence cumulated in the past 30 years has linked ischemic neuronal death to the overactivation of glutamatergic ionotropic receptors (NMDA, N-Methyl-D-aspartate and AMPA, α-amino3-hydroxy-5-methyl-4-isoxazolepropionic-acid), a process that leads to massive Ca2+ entry into neurons and activation of a plethora of Ca2+-dependent injurious pathways. NMDAR associated channels are highly Ca2+ permeable and seem to play a prominent role in ischemic neuronal death. Most of the AMPAR associated channels are Ca2+ impermeable; nevertheless, AMPAR activation is also able to mediate neurotoxic rises of intracellular Ca2+ ([Ca2+]i) via indirect opening of the voltage sensitive Ca2+ channels (VSCC). Parenchymal acidosis is another key component of the injurious pathways set in motion by cerebral ischemia (2), as well as an important modulator of excitotoxicity. NMDAR-mediated currents are attenuated by moderate extracellular acidity in the range of pH 6.2–7.2 (3, 4), and in vitro, reduction of extracellular pH below 6.5 reduces both glutamate and oxygen-glucose deprivation induced neurotoxicity (5, 6, 7). While acidosis can reduce NMDAR-dependent neuronal loss, we previously have shown that lowering the extracellular pH can enhance AMPAR-mediated neuronal injury (8). Such enhanced toxicity originally was explained partially by increased [Ca2+]i deregulation. In the Mcdonald study, we also found that neurons challenged with AMPA (under non-desensitizing conditions) undergo a phase of delayed recovery of [Ca2+]i levels when washed in an acidic (pH 6.6) buffer. Using Ca2+ imaging experiments, this delayed recovery was attributed to deregulation of [Ca2+]i homeostatic mechanisms, as evaluation of Ca2+ influx by 45Ca2+ uptake showed that influx of the cation via VSCC was decreased by extracellular acidity.
Excitotoxic neuronal loss also has been linked to the dyshomeostasis of another divalent cation, Zn2+. A large amount of data supports the idea that Zn2+ can in fact act not only as a cellular messenger, but also as a potent trigger of neuronal death through several mechanisms — including energy depletion, reactive oxygen species (ROS) generation, and mitochondrial dysfunction, reviewed in (9). Injurious [Zn2+]i rises have been linked to excitotoxic conditions such as transient global ischemia, head trauma, and epilepsy (10). Elevations of [Zn2+]i are due to a combination of influx of the cation via glutamate receptors and VSCC activation, as well as its release from intracellular sites. Intracellularly Zn2+ is loosely bound to proteins such as metallothioneins (MTs) and several studies have indicated that the cation can be mobilized from MTs under conditions of oxidative stress. Further studies have shown that Zn2+ also can be mobilized in a Ca2+-dependent fashion from mitochondria (11, 12). Interestingly, changes in the intracellular proton concentration appear to act as a co-factor in ROS-mediated [Zn2+]i rises as a decrease in pH rapidly destabilizes Zn2+ binding to MTs (13) and promotes an overall release of the cation. This phenomenon has now been confirmed in neurons, where mild acidosis has been found to dramatically increase [Zn2+]i rises induced by MT oxidation (12).
A very intriguing debate has recently emerged in the excitotoxic field: the “Calcium- Zinc dilemma” (9,12,14, 15, 16). While for many years excitotoxicity has been interpreted as a purely Ca2+-dependent process, most of the evidence for the Ca2+-dependency derives from experimental paradigms that made use of either Ca2+ chelators or intracellular Ca2+ imaging with Ca2+ sensitive fluorescent indicators. One problem with this “Ca2+-centered” view comes from the fact that both Ca2+ fluorescent probes and chelators also bind Zn2+, and in fact do so with higher affinity. The potential confounding effect of Zn2+ on Ca2+ imaging has been neglected, moving from the assumption that [Zn2+]i levels are very low. However, as mentioned above, a wealth of evidence has been gathered in recent years demonstrating that upon pathophysiological conditions (i.e. oxidative and nitrosative stress; NMDAR activation and oxygen-glucose deprivation) [Zn2+]i rises can reach levels high enough to greatly interfere with fluorescent measurements of [Ca2+]i and/or chelation by divalent chelators (12,14,16, 17). Thus, in this study, we critically re-examined our previous results (8) and investigated whether the AMPAR-mediated changes in fura-2 fluorescence signals that we originally interpreted as purely Ca2+-dependent could be also linked to [Zn2+]i rises.
Materials and Methods
FluoZin-3 AM, fura-2 AM, and hydroethidine (Het) were purchased from Molecular Probes (Invitrogen, Milan, Italy). Carbonyl cyanide 3-chlorophenyl-hydrazone (CCCP), and N,N,N′,N′-Tetrakis-(2-pyridylmethyl)ethylene-diamine (TPEN) were obtained from Sigma-Aldrich (Milan, Italy). Tissue culture media and serum were from Gibco (Invitrogen, Milan, Italy). All other chemicals and reagents were obtained from common commercial sources.
Animal Cell Cultures
All animal procedures were approved by the institutional animal care and use committee. Murine cortical cultures were prepared from embryonic CD1 mice and neurons plated upon astrocytic mono-layers on poly-lysine + laminin coated cover slips as previously described (18).
Fura-2, FluoZin-3, and HEt Microfluorimetric Studies
Fluorescence imaging was carried out using an inverted microscope with a xenon lamp, filter wheel, at 40X, epifluorescence oil immersion objective and fluorescent cubes. For ratiometric fura-2 imaging, cultures were loaded in the dark, with 3 µM of the acetoxymethyl ester form of the probe in a HEPES-buffered medium (HCSS) whose composition was (in mM): 120 NaCl, 5.4 KCl, 0.8 MgCl2, 20 HEPES, 15 glucose, 1.8 CaCl2, 10 NaOH, pH 7.4 for 30 min at 25°C, then washed in HCSS and kept in the dark for an additional 30 min, excitation was at 340 and 380 nm, with emission at 510 nm. For Zn2+ imaging, cells were loaded with the same protocol using 5 µM of FluoZin-3 AM, excitation was at 490 nm and emission at 530 nm. Experiments were carried out at room temperature (25°C). Drugs were applied by bath application and removed through a rapid flow exchange system. Images were acquired with a 12-bit digital CCD camera and analyzed (after background subtraction from a cell-free region of the dish) with Metafluor 6.0 software (Universal Imaging, West Chester, PA, USA).
Oxygen radical production was monitored using the oxidation sensitive dye, HEt. Stock HEt (1 mg/mL) was prepared as previously described (11) in dry DMSO and stored in frozen aliquots for use within eight weeks. Cultures were loaded in the dark with 5 µM HEt in HCSS (45 min, 25°C). After loading, cultures were washed (4×) in a static bath of HCSS containing 5 µM HEt. Cells were excited at 510–560 nm and emission monitored at > 590 nm.
Fura-2, FluoZin-3, and HEt fluorescence measurements for each cell (Fx) were normalized to either the fluorescence intensity (Fluozin-3 and HEt) or 340/380 ratio (fura-2) for that cell at the beginning of the experiment (F0) and changes over time expressed as percentage increase over baseline.
Experiment Replication and Statistics
All experiments reported represent at least three independent replications. Comparisons were obtained by Student-Newman-Keuls’ test (P < 0.01).
Mobilization of [Zn2+]i can occur from MT oxidation as well as from Zn2+ release from mitochondria (12,14,17). We first explored the possibility that AMPAR activation can induce release of Zn2+ present in mitochondria. In FluoZin-3 loaded cultures, exposure to a protonophore (CCCP; 1 µM) that collapses the mitochondrial membrane potential and, as shown before (11, 12) promotes Zn2+ release from mitochondria, produced a large increase in cytosolic FluoZin-3 fluorescence. Suggesting that mitochondria are a likely source for AMPAR-mediated [Zn2+]i rises, CCCP exposure also occluded subsequent responses to kainate (Figure 3B).
Our present study complements previous Ca2+ imaging studies in both neuronal cultures and hippocampal slices and clearly indicates that excitotoxic activation of glutamate receptors leads not only to [Ca2+]i dyshomeostasis but also to a significant [Zn2+]i mobilization. This idea is substantiated by the interpretation of the increases in both fura-2 ratios and FluoZin-3 fluorescence (quenched by TPEN) that we observed. Fura-2 has a low affinity for Mg2+ (Kd 6–10 mM) and exhibits an affinity for Zn2+ that is nearly 100-fold higher than its affinity for Ca2+ (Kd 0.5–3 nM). Upon Zn2+ binding, fura-2 fluorescence undergoes changes similar to what is observed with Ca2+ (i.e. increases of the 340/380 nm excitation ratio). On the other hand, fura-2 binding to transition metals likely to be intracellularly released in significant amounts, such as manganese, ferrous and ferric iron, and copper results in different levels of quenching of the probe fluorescence.
FluoZin-3 is a Zn2+ selective indicator that exhibits high Zn2+ binding affinity (Kd for Zn2+ |15 nM), that is unperturbed by Ca2+ and Mg2+ concentrations up to at least 0.1 mM and 1 M respectively (20). As with fura-2, iron and copper binding to FluoZin-3 produce quenching of the probe fluorescence. Thus, the only metal that could promote TPEN-sensitive increases in both fura-2 ratios and FluoZin-3 fluorescence is Zn2+.
Our findings reinforce the idea that glutamate receptor overactivation can trigger a synergistic injurious interplay between Ca2+ and Zn2+. Considering the fact that Zn2+ is able to induce neuronal loss with greater potency compared with Ca2+, the cation might soon emerge as the major ionic determinant of excitotoxicity. Indeed, given the fact that significant [Zn2+]i release from mitochondria can result from large, NMDAR-triggered [Ca2+]i rises, and the likely probability that Ca2+-induced mitochondrial ROS generation could also trigger Zn2+ mobilization from MTs, we might envision a pathological setting in which glutamate receptor-driven [Ca2+]i rises actually play a more modest injurious role than previously thought. Instead of being the executioner, [Ca2+]i dyshomeostasis can actually serve as an “accomplice” to deregulate the intracellular concentrations of the primary ionic mediator of neuronal injury, Zn2+.
This study also integrates the main results of our previous experiments with the novel finding that reduction of extracellular pH to levels of parenchymal acidosis associated with cerebral ischemia (2) enhances AMPAR-mediated Zn2+ dyshomeostasis.
The connection between Zn2+ and acidosis is intriguing as pH reduction can affect many Zn2+ homeostatic systems. The permeability of major routes of Zn2+ entry, such as the VSCC and Ca2+-permeable AMPAR, is enhanced at acidic pH, while the Ca2+ permeability of these channels (as well as NMDAR permeability) has been shown to be decreased under the same conditions (22, 23). Zn2+ uptake and compartmentalization by Zinquin-positive cytosolic organelles is blocked by intracellular acidification, indicating the presence of a putative intracellular Zn2+/proton antiporter (24), and previous studies have also indicated that an acidotic environment can greatly destabilize Zn2+ binding to MTs and therefore promote [Zn2+]i accumulation (13). Interestingly, Zn2+ dyshomeostasis itself can alter the intracellular acid-base equilibrium and promote a feed-forward dyshomeostatic loop. Findings in cultured neurons suggest that Zn2+ can in fact favor intracellular acidification in a Ca2+-dependent fashion through an increased activity of the Na+/Ca2+ exchanger, and also maintain such acidification by Zn2+-dependent inhibition of proton efflux via the Cl-/HCO3- exchanger (25). Finally, as observed in our study, prolonged intracellular acidosis could further evoke [Zn2+]i dyshomeostasis by interfering with the overall neuronal redox state, either by reducing the activity of cellular antioxidant enzymes or increasing hydroxyl radical formation (26).
In our study, it appears that the acidotic/AMPAR-mediated [Zn2+]i rises observed in neuronal cultures can be attributed to combined mechanisms of mitochondrial release of the cation together with impaired buffering by MTs. The fact that mitochondrial depolarization prior to the kainate exposure completely occludes AMPAR-mediated [Zn2+]i increases seems to indicate that most of the Zn2+ is released from that subcellular compartment (Figure 3B). On the other hand, the impaired Zn2+ buffering under acidotic conditions that follows AMPAR activation appears to be related to a synergistic inhibition on Zn2+ binding to MTs that is promoted by protons either directly (13), or indirectly, by enhancing AMPAR-mediated ROS production. This process eventually leads to MT oxidation and further decreased Zn2+ buffering.
On a speculative note, our model, which emphasizes the role played by acidosis and AMPAR-mediated Zn2+ dyshomeostasis in excitotoxicity, might be relevant for the timing and selection of pharmacological intervention in neurological conditions associated with both acidosis and alteration of [Zn2+]i content such as stroke, status epilepticus, and trauma. While hours away from the ischemic attack when the acid-base equilibrium is restored, NMDAR antagonists maintain a very important therapeutic value, AMPAR antagonists might result as a better option immediately after the insult given the fact that NMDARs are already blocked by post-ictal parenchymal acidosis (27). The importance of AMPAR antagonism has been demonstrated recently by an elegant series of studies in which blockade of the Ca2+-permeable AMPARs has been found to be neuroprotective both in “in vitro” and “in vivo” models of cerebral ischemia (28, 29, 30). Work by our laboratory and the groups of Suzanne Zukin and Mike Bennett has convincingly demonstrated that, in the post-ischemic period, blockade of Ca-A/K channels by spermine derivatives can greatly inhibit neuronal death in the CA1 hippocampal region by counteracting both [Zn2+]i accumulation and Zn2+-dependent injurious processes.
Targeting Zn2+ dyshomeostasis might also require further exploration, as recent animal studies involving the use of pyruvate to restore Zn2+-dependent injurious depletion of cytosolic NAD+ levels showed a dramatic neuroprotective effect in the context of both global and focal cerebral ischemia (31, 32).
A final technical issue raised by our findings concerns the need for highly selective Ca2+-sensitive fluorescent probes. The warning contained in the paper by Grynkiewicz, Poenie and Tsien (33) indicating the high sensitivity of Ca2+-sensitive fluorescent probes to heavy metals has been neglected. It is now clear that mobilization of intracellular Zn2+ can be a significant contributor to the fluorescence changes of Ca2+ fluorescent probes. This effect should no longer be ignored nor Ca2+ dependency claimed without a prior careful exclusion of Zn2+-dependent phenomena.
We thank Tiziana D’Ettorre and Francesca Faricelli for expert assistance with cell cultures. This work was supported by PRIN 2004, FIRB 2003, and PRIN 2006 (SLS).
- 19.Arslan P, Di Virgilio F, Beltrame M, Tsien RY, Pozzan T. (1985) Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas. A new, membrane-permeant chelator of heavy metals reveals that these ascites tumor cell lines have normal cytosolic free Ca2+. J. Biol. Chem. 260:2719–27.PubMedGoogle Scholar
- 23.Jeng J-M, Jia, Y., Bonanni, L., Weiss, J.H. (2002) Divergent effects of pH on Zn2+ and Ca2+ flux through Ca2+-permeable AMPA/kainate channels (CAKR) SFN Annual Meeting. Washington, DC: Society for Neuroscience, Orlando, FL, p.539.Google Scholar